Characterization of the 3p12.3-pcen region associated with tumor suppression in a novel ovarian cancer cell line model genetically modified by chromosome 3 fragment transfer.
about
The TEAD Family and Its Oncogenic Role in Promoting TumorigenesisCGGBP1--an indispensable protein with ubiquitous cytoprotective functionsRole of Genetic Polymorphisms in the Development and Prognosis of Sporadic and Familial Prostate CancerChromosome 3 anomalies investigated by genome wide SNP analysis of benign, low malignant potential and low grade ovarian serous tumours.VGLL3 expression is associated with a tumor suppressor phenotype in epithelial ovarian cancerMicroarray enriched gene rank3'UTR elements inhibit Ras-induced C/EBPβ post-translational activation and senescence in tumour cellsProstate cancer susceptibility polymorphism rs2660753 is not associated with invasive ovarian cancerLow levels of IGFBP7 expression in high-grade serous ovarian carcinoma is associated with patient outcome.NotI microarrays: novel epigenetic markers for early detection and prognosis of high grade serous ovarian cancer.Emerging roles of TEAD transcription factors and its coactivators in cancersProteome Characterization of Human Pancreatic Cyst Fluid from Intraductal Papillary Mucinous Neoplasm by LC/MS/MS.From vestigial to vestigial-like: the Drosophila gene that has taken wing.Vestigial-like 3 is a novel Ets1 interacting partner and regulates trigeminal nerve formation and cranial neural crest migration.CADM2, as a new target of miR-10b, promotes tumor metastasis through FAK/AKT pathway in hepatocellular carcinoma.Identification of genomic aberrations associated with lymph node metastasis in diffuse-type gastric cancer.
P2860
Q26775126-15311904-E8D5-4E3F-8F76-9E0B8DD46FD8Q26781725-D78C9653-22D9-46D0-AADF-341168C9890AQ28554766-E978C49E-DC18-446C-BED4-0B41C5C8B826Q34097804-3CDF4F0A-0B63-4D3F-B6F4-7E27F52EF170Q34328133-B775F12F-DEDD-4B38-ADAE-DF452C128BE6Q35008782-7BDF6B86-C6DF-4012-A637-98220F072D03Q35214891-61472186-4E50-4909-91AF-BEDD983C41ECQ35223068-834F71DF-234C-4FB3-BF83-ED0694A01931Q35237915-E5C471F2-C573-4F14-8F0F-61887D2FA970Q36396570-43E29813-507F-4DAC-AFD9-F8B84D523FCEQ36901489-B6DFC30D-6D76-4F15-91EF-4EB0574D8585Q38372053-B503B806-0C34-4A81-835E-46A0C1E82676Q38818139-97A44EFE-4B52-48F4-AB58-1C0847A5D9E7Q47168676-4FB3684E-5A2D-4383-8765-7E08578857EEQ52673537-C669ADF1-31D8-47FC-B7AB-621FCA07CA94Q55002251-6303CB5D-0C65-4893-A3C3-87E4272E96E1
P2860
Characterization of the 3p12.3-pcen region associated with tumor suppression in a novel ovarian cancer cell line model genetically modified by chromosome 3 fragment transfer.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Characterization of the 3p12.3 ...... hromosome 3 fragment transfer.
@en
Characterization of the 3p12.3 ...... hromosome 3 fragment transfer.
@nl
type
label
Characterization of the 3p12.3 ...... hromosome 3 fragment transfer.
@en
Characterization of the 3p12.3 ...... hromosome 3 fragment transfer.
@nl
prefLabel
Characterization of the 3p12.3 ...... hromosome 3 fragment transfer.
@en
Characterization of the 3p12.3 ...... hromosome 3 fragment transfer.
@nl
P2093
P356
P1476
Characterization of the 3p12.3 ...... hromosome 3 fragment transfer.
@en
P2093
Anne-Marie Mes-Masson
Diane M Provencher
Jean-Sebastien Ripeau
Mario Chevrette
Neal A L Cody
Patricia N Tonin
P304
P356
10.1002/MC.20535
P577
2009-12-01T00:00:00Z